Wednesday, January 06, 2016 9:58:22 AM
Known Upcoming Events...
Jan9: AACR's The Function of Tumor Microenvironment in Cancer Progression Conf., SanDiego http://tinyurl.com/oo37gwr
...Dr. Rolf Brekken (UTSW, PPHM SAB): “Antibody mediated blockade of PS synergizes with immune checkpoint blockade by inhibiting multiple immune suppressive mechanisms”
.....note: the chair in Dr.Brekken's “Actions of Innate & Adaptive Immunity” session is Dr. Joan Massague, DIRECTOR of The Memorial Sloan Kettering Inst.
Jan25: Phacilitate's Immunotherapy World Conf., WashDC http://tinyurl.com/zjd7h4n
...3:40-3:55pm, Dr. Jeff Hutchins (VP/PreClinRes): “Combination Immunotherapies - Opening the Gate: Increasing Tumor Infiltrating Activated T-cells to Optimize & Expand the Benefits of Immune Checkpoint Therapies”
Jan26: GTCbio's Novel Immunotherapeutics Summit, San Diego http://tinyurl.com/z3dyful
...10am, Dr. Bruce Freimark (ResDir./Preclin.Oncology): “Blockade of PS Enhances the Anti-Tumor Activity of Targeted Therapy & Immune Checkpoint Inhibitors by Reducing Immunosuppressive Cells in the Tumor Microenvironment”
Jan26-28/Avid/Booth20: CASSS' 20th Symposium on the Interface of Reg.&Anal. Sciences for Biotech Health Products, WashDC http://www.casss.org/?WCBP1600
Mar8: CHI’s Inaugural Cancer Immunotherapy Conf., SanFran http://tinyurl.com/hlskng8
...3:55pm, Dr. Jeff Hutchins (VP/PreClinRes), Track Chair: “Combination Immunotherapies – Opening the Gate: Increasing Tumor Infiltrating Activated T-Cells to Optimize & Expand the Benefits of Immune Checkpoint Therapies”
~Mar10: FY'16Q3 (qe 1-31-16) Financials & Conf. Call http://ir.peregrineinc.com/events.cfm
Mar14-17/Avid/Booth712: IBC's BioProcess Intl. West, Oakland http://www.ibclifesciences.com/BPIWest/overview.xml
Mar16: Immune Checkpoint Inhibitors Conf., Boston http://tinyurl.com/hzjjs2u (Peregrine is 1 of 8 Corp. Sponsors)
...2pm, Dr. Jeff Hutchins (VP/PreClinRes): “Enhancing the Power of Checkpoint Inhibition by Simultaneously Blocking Upstream & Downstream Targets: The Role of PS, a Novel, Global Immune Checkpoint”
??Apr16-20: AACR 2016, New Orleans http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=63
??Jun3-7: ASCO 2016, Chicago http://am.asco.org
Jun6-9/Avid/Booth5562: BIO Intl. Convention, SanFran http://convention.bio.org
~Jul12: FY'16Q4 (fy/e 4-30-16) Financials & Conf. Call http://ir.peregrineinc.com/events.cfm
Jan9: AACR's The Function of Tumor Microenvironment in Cancer Progression Conf., SanDiego http://tinyurl.com/oo37gwr
...Dr. Rolf Brekken (UTSW, PPHM SAB): “Antibody mediated blockade of PS synergizes with immune checkpoint blockade by inhibiting multiple immune suppressive mechanisms”
.....note: the chair in Dr.Brekken's “Actions of Innate & Adaptive Immunity” session is Dr. Joan Massague, DIRECTOR of The Memorial Sloan Kettering Inst.
Jan25: Phacilitate's Immunotherapy World Conf., WashDC http://tinyurl.com/zjd7h4n
...3:40-3:55pm, Dr. Jeff Hutchins (VP/PreClinRes): “Combination Immunotherapies - Opening the Gate: Increasing Tumor Infiltrating Activated T-cells to Optimize & Expand the Benefits of Immune Checkpoint Therapies”
Jan26: GTCbio's Novel Immunotherapeutics Summit, San Diego http://tinyurl.com/z3dyful
...10am, Dr. Bruce Freimark (ResDir./Preclin.Oncology): “Blockade of PS Enhances the Anti-Tumor Activity of Targeted Therapy & Immune Checkpoint Inhibitors by Reducing Immunosuppressive Cells in the Tumor Microenvironment”
Jan26-28/Avid/Booth20: CASSS' 20th Symposium on the Interface of Reg.&Anal. Sciences for Biotech Health Products, WashDC http://www.casss.org/?WCBP1600
Mar8: CHI’s Inaugural Cancer Immunotherapy Conf., SanFran http://tinyurl.com/hlskng8
...3:55pm, Dr. Jeff Hutchins (VP/PreClinRes), Track Chair: “Combination Immunotherapies – Opening the Gate: Increasing Tumor Infiltrating Activated T-Cells to Optimize & Expand the Benefits of Immune Checkpoint Therapies”
~Mar10: FY'16Q3 (qe 1-31-16) Financials & Conf. Call http://ir.peregrineinc.com/events.cfm
Mar14-17/Avid/Booth712: IBC's BioProcess Intl. West, Oakland http://www.ibclifesciences.com/BPIWest/overview.xml
Mar16: Immune Checkpoint Inhibitors Conf., Boston http://tinyurl.com/hzjjs2u (Peregrine is 1 of 8 Corp. Sponsors)
...2pm, Dr. Jeff Hutchins (VP/PreClinRes): “Enhancing the Power of Checkpoint Inhibition by Simultaneously Blocking Upstream & Downstream Targets: The Role of PS, a Novel, Global Immune Checkpoint”
??Apr16-20: AACR 2016, New Orleans http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=63
??Jun3-7: ASCO 2016, Chicago http://am.asco.org
Jun6-9/Avid/Booth5562: BIO Intl. Convention, SanFran http://convention.bio.org
~Jul12: FY'16Q4 (fy/e 4-30-16) Financials & Conf. Call http://ir.peregrineinc.com/events.cfm

